Viral latency is a reversible state of infection in which a virus maintains its genetic material within a host cell without sustained production of infectious progeny. The viral genome remains capable of resuming productive infection through a process called reactivation. Latency is a cellular state rather than simply an absence of symptoms: an infected individual may have latent virus in some cells while productive infection occurs elsewhere. It is characteristic of herpesviruses and is central to the persistence of human immunodeficiency virus (HIV).
Definition and distinctions
During productive infection, viral genes direct the synthesis of viral components and the formation of new infectious particles. During latency, this productive program is suppressed or interrupted, while the viral genome is retained. Latency does not necessarily mean complete molecular inactivity. Some latent viruses express restricted sets of genes or regulatory RNAs, and viral genomes may be copied when their host cells divide.
Several related terms describe different aspects of infection:
- Persistent infection is the broader category in which a virus remains in a host over an extended period. Persistence may involve latency, continuous production of virus, or alternating patterns.
- Chronic productive infection involves continuing virus production, although its level may fluctuate.
- Asymptomatic infection means infection without apparent symptoms. It can be productive and transmissible and therefore is not equivalent to latency.
- Incubation period is the interval between infection and the onset of symptoms. It does not identify a particular molecular state of the virus.
- The latent period in transmission studies is the interval between infection and the onset of infectiousness. This epidemiological usage is distinct from cellular viral latency.
A further distinction concerns defective viral genomes. A genome that cannot produce infectious virus because essential sequences have been lost is not, by that fact alone, a replication-competent latent infection. This distinction is especially important when measuring viral reservoirs.
Establishment and maintenance
Latency depends on the interaction between viral regulatory mechanisms, the state of the infected cell, and host defenses. A virus must preserve its genome while limiting the processes that would otherwise produce new particles, damage the cell, or expose it to immune recognition.
Genome persistence
Latent viral genomes can persist in different physical forms.
In many herpesvirus infections, viral DNA remains in the nucleus as an episome, separate from the host chromosomes. In dividing cells, some herpesviruses use viral proteins to ensure that episomes are copied and distributed to daughter cells. In long-lived, nondividing cells, persistence does not require this repeated distribution.
For HIV, viral RNA is copied into DNA, which can become integrated into a host chromosome. This integrated DNA, called a provirus, may enter a transcriptionally restricted state. Integration alone does not establish latency: integrated proviruses can also be actively expressed.
Restriction of viral gene expression
Latency commonly involves control of gene expression, particularly transcription. Viral DNA associates with cellular chromatin, and its accessibility to the transcriptional machinery can change. Histone modifications, regulatory proteins, and, in some contexts, DNA methylation contribute to repression or activation.
Viral factors can reinforce this state by suppressing productive-cycle genes, regulating cell survival, or modifying cellular signaling. Host-cell conditions also matter. The availability of transcription factors, the cell’s developmental state, and its activation status can influence whether a viral genome remains silent or becomes active.
Latency is therefore not a single universal mechanism. Different viruses use distinct strategies, and even genetically similar viral genomes may behave differently in different cells.
Major examples
Herpesviruses
Members of the herpesvirus family establish long-term latent infections, but their principal cellular reservoirs differ.
| Virus | Principal cells associated with latency | Characteristic feature |
|---|---|---|
| Herpes simplex viruses 1 and 2 | Sensory neurons | Reactivation can lead to recurrent mucocutaneous infection or asymptomatic shedding |
| Varicella-zoster virus | Neurons in sensory and autonomic ganglia | Reactivation causes shingles |
| Epstein–Barr virus | B lymphocytes, especially memory B cells | Different latency programs express different combinations of viral genes |
| Human cytomegalovirus | Cells of the myeloid lineage, including hematopoietic progenitor cells and monocytes | Cell differentiation can help initiate reactivation |
| Kaposi sarcoma-associated herpesvirus | B lymphocytes and endothelial-lineage cells | Latent genes support genome maintenance and alter cellular functions |
Herpes simplex latency in neurons illustrates persistence in long-lived cells. By contrast, Epstein–Barr virus can persist within the long-lived memory B-cell compartment, with its genome maintained as infected cells survive or divide.
Herpesvirus latency is not always transcriptionally silent. Epstein–Barr virus, for example, has several recognized latency programs. Some involve expression of multiple viral proteins; others involve much more restricted expression.
HIV
HIV establishes a particularly important latent reservoir in resting memory CD4-positive T cells. Some of these cells contain integrated, replication-competent proviruses that produce little or no virus until cellular conditions change.
Antiretroviral therapy suppresses viral replication but does not reliably eliminate these proviruses. Long-lived infected cells and the proliferation of infected cell populations help maintain the reservoir. When therapy is interrupted, reactivation of reservoir viruses can contribute to renewed virus production.
Most HIV DNA detected during suppressive therapy is defective. Consequently, measuring all HIV DNA does not directly measure the number of cells capable of producing infectious virus.
Reactivation and immune control
Reactivation is the transition from latent persistence to renewed productive infection. It usually requires activation of viral regulatory genes followed by a coordinated program of genome replication, viral protein production, and particle formation.
The signals involved depend on the virus and the reservoir cell. Changes in cellular activation, differentiation, stress signaling, or immune control can influence reactivation. For example, activation of a latently infected T cell can provide factors needed for HIV transcription, while differentiation of myeloid cells can favor cytomegalovirus reactivation. No single trigger explains every reactivation event.
The immune system limits viral spread and helps contain reactivation. Reduced viral protein expression during latency can make infected cells less visible to immune responses, although latency does not necessarily make them completely invisible. Immune surveillance can restrain infection without eliminating every infected cell.
Reactivation need not cause recognizable disease. It may be restricted locally or result in asymptomatic shedding. Conversely, impaired immune control can allow some reactivated viruses to cause substantial tissue injury.
Relationship to bacteriophage lysogeny
A related form of persistence occurs in bacteriophages, viruses that infect bacteria. In lysogeny, a temperate phage genome persists as a prophage, often integrated into the bacterial chromosome, while genes needed for productive infection are repressed. The prophage can be maintained as the bacterium divides and can later be induced to enter a productive cycle.
Lysogeny and animal-virus latency share the principles of genome maintenance, restricted productive gene expression, and reversibility. They are not identical processes: their regulatory systems, host environments, and routes to productive infection differ. In bacteriophage growth experiments, latent period also refers to the interval before progeny phages are released, a separate use of the term.
Detection and research limitations
Demonstrating latency requires more than detecting viral genetic material. Polymerase chain reaction can reveal viral DNA, but a positive result alone does not establish whether the genome is intact, transcriptionally active, or capable of producing infectious virus. Detecting viral RNA or proteins provides information about activity, but restricted expression can occur during latency.
Researchers combine several approaches:
- Genome measurements estimate the amount and integrity of viral genetic material.
- Expression measurements identify viral transcripts and proteins associated with latent or productive states.
- Reactivation assays test whether infected cells can produce infectious virus under particular experimental conditions.
- Cellular and tissue analyses identify reservoir cell types and their anatomical locations.
Each approach has limitations. Reactivation assays can miss competent genomes that fail to respond to the chosen stimulus. Genetic assays can count defective genomes. Blood samples may poorly represent reservoirs in tissues or nervous-system ganglia. Experimental cell models also cannot reproduce every feature of naturally infected cells.
These limitations matter for diagnosis and for research on eliminating persistent infections. A decline in detectable viral DNA does not necessarily demonstrate eradication, and failure to induce virus in a laboratory assay does not prove that all remaining genomes are permanently inactive.